BEIJING, Feb. 28, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that the Company's growing business earned a BBB+ Credit Rating from the Beijing Zhongguancun Enterprises Credit Promotion Association (the "Zhongguancun Association") and was approved as a member of the association.
BBB+ rating reflects Dehaier's competitiveness in the industry, relatively strong enterprise system, sustainable business model, rapid growth, profitability and low credit risk.
The Association is managed by Beijing Zhongguancun Sci-Tech Guaranty Co., Ltd (the "Zhongguancun Guaranty Company"), established in 1999. Zhongguancun Guaranty Company is a policy-based credit guaranty organization funded by the Chinese government and one of China's most influential domestic guaranty organizations. The National Development and Reform Committee of Beijing has chosen the Zhongguancun Guaranty Company as China's national guaranty organization innovation training base. The Zhongguancun Guaranty Company provides enterprises with different credit guaranty ratings and is the guarantor responsible for the organizations that extend credit to the enterprises according to rating results.Dehaier Medical obtained the approval and high rating as a result of its strong reputation within the corporate and medical community in Beijing and healthy financial position. Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical stated, "We are very pleased to have received this acknowledgement from such a well-known agency in Beijing. Since our inception, our company has made a commitment to hold itself to the highest standard of corporate governance and creditworthiness. We remain devoted to building a highly transparent, open, and trustworthy listed firm." About Dehaier Medical Systems Ltd. Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD ( Italy), Welch Allyn ( USA), HEYER ( Germany), Timesco (UK), eVent Medical (US) and JMS ( Japan). Dehaier's technology is based on six patents and five software copyrights; additionally Dehaier has two pending software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn. Forward-looking Statements This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular statements about Dehaier's membership in the Zhongguancun Association and the meaning of and retention of any ratings granted to Dehaier (including any factors affecting such ratings). These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.